Oncology Institute (DFPH) Other Operating Expenses (2021 - 2026)

Oncology Institute (DFPH) has reported Other Operating Expenses for 6 consecutive years, with $124.8 million the latest figure, recorded in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $124.8 million, up 41.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $466.2 million (up 34.36% YoY), and the FY2025 annual result was $429.3 million, up 25.33% from the prior year.
• Other Operating Expenses was $124.8 million for Q1 2026 at Oncology Institute, up from $119.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $124.8 million in Q1 2026 and troughed at $43.5 million in Q1 2022.
• Average Other Operating Expenses over 5 years is $82.0 million, with a median of $83.5 million recorded in 2024.
• Year-over-year, Other Operating Expenses jumped 83.14% in 2023 and grew 4.75% in 2024.
• Over 5 years, Other Operating Expenses stood at $66.5 million in 2022, then rose by 8.59% to $72.2 million in 2023, then grew by 19.71% to $86.4 million in 2024, then surged by 38.78% to $119.9 million in 2025, then advanced by 4.11% to $124.8 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $124.8 million in Q1 2026, $119.9 million in Q4 2025, and $118.4 million in Q3 2025.